| 中文名称 |
TCS7010
|
| 中文别名 |
N-(2-氯苯基)-4-(2-(4-(2-(4-乙基哌嗪-1-基)-2-氧代乙基)苯基氨基)-5-氟嘧啶-4-基氨基)苯甲酰胺;N-(2-氯苯基)-4-[[2-[[4-[2-(4-乙基-1-哌嗪基)-2-氧代乙基]苯基]氨基]-5-氟-4-嘧啶基]氨基]苯甲酰胺;Aurora A Inhibitor I
|
| 英文名称 |
TCS7010
|
| 英文别名 |
N-(2-Chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenyl)amino)-5-fluoropyrimidin-4-yl)amino)benzamide;Aurora A inhibitor I;Benzamide, N-(2-chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]-;N-(2-chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenyl)amino)-5-fluoropyrim...;N-(2-Chlorophenyl)-4-((2-((4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)-phenyl)amino)-5-fluoropyrimidin-4-yl)amino)benzamide;TC-S 7010;2,4-Bisanilinopyri;CHEMBL502124;HMS3265K21;N-(2-chlorophenyl)-4-{[2-({4-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]phenyl}amino)-5-fluoropyrimidin-4-yl]amino}benzamide;S1451_Selleck;N-(2-Chlorophenyl)-4-(2-(4-(2-(4-ethylpiperazin-1-yl)-2-oxoethyl)phenylamino)-5-fluoropyrimidin-4-ylamino)benzamide;N-(2-Chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]-benzamide;TCS7010
|
| Cas No. |
1158838-45-9
|
| 分子式 |
C31H31N7O2FCl
|
| 分子量 |
588.08
|
| 包装储存 |
Powder -20°C 3 years;4°C 2 years
|
| 详情描述 |
TCS7010 是有效,高度选择的 Aurora A 抑制剂,IC50 值为 3.4 nM。
|
| 产品详情 |
TCS7010 是有效,高度选择的 Aurora A 抑制剂,IC50 值为 3.4 nM。
|
| 生物活性 |
TCS7010 is a potent and highly selective Aurora A inhibitor with with an IC 50 of 3.4 nM.
|
| 性状 |
Solid
|
| IC50 & Target[1][2] |
Aurora A 3.4 nM (IC50) Aurora B 3.4 μM (IC
|
| 体外研究(In Vitro) |
TCS7010 is exceptionally selective Aurora A inhibitors. TCS7010 is an useful tool compounds for investigating the cellular role of Aurora A kinases without the complication of also inhibiting Aurora B. has not independently confirmed the accuracy of these methods. They are for reference only.
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
Powder -20°C 3 years;4°C 2 years
|
| 参考文献 |
[1]. Aliagas-Martin I, Burdick D, Corson L, Dotson J, Drummond J, Fields C, Huang OW, Hunsaker T, Kleinheinz T, Krueger E, Liang J, Moffat J, Phillips G, Pulk R, Rawson TE, Ultsch M, Walker L, Wiesmann C, Zhang B, Zhu BY, Cochran AG.A class of 2,4-bisanilinopy
|
| 溶解度数据 |
In Vitro: DMSO : 50 mg/mL (85.02 mM; Need ultrasonic)配制储备液
|
[1]. Aliagas-Martin I, Burdick D, Corson L, Dotson J, Drummond J, Fields C, Huang OW, Hunsaker T, Kleinheinz T, Krueger E, Liang J, Moffat J, Phillips G, Pulk R, Rawson TE, Ultsch M, Walker L, Wiesmann C, Zhang B, Zhu BY, Cochran AG.A class of 2,4-bisanilinopy
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。